Navigation Links
ECLIPSE Data on Effects of Otsuka's Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients' Hemodynamics and Urine Output Featured in Heart Failure Society of America's Late Breaking Trials
Date:9/19/2007

onary edema, and an estimate of the filling pressures of the left side of the heart.

Compared with placebo, each dose of tolvaptan significantly increased urine volume at 3 hours after dose was given (p<0.0001). Also, during the three to eight hour interval after tolvaptan administration, mean reductions of the pressure in the pulmonary artery that carries venous blood from the right ventricle of the heart to the lungs, a secondary endpoint, were observed and were statistically greater (p<0.05) in all tolvaptan groups than in the placebo group. Over the same time period, mean reductions in pressure within the heart's right atrium were also observed, and those were statistically greater in the tolvaptan 15 mg and 30 mg groups than in the placebo group. None of the other secondary outcome measures, including cardiac output (the amount of blood the heart's left ventricle ejects into the circulation in one minute), cardiac index (cardiac output indexed to a patient's body size), systemic vascular resistance (the resistance to blood flow by all of the blood vessels, excluding those in the lungs), heart rate, and blood pressure, showed significantly different changes in the tolvaptan and placebo groups.

Overall, 77 (42.5%) subjects experienced at least one treatment-emergent adverse event during the trial. The incidence of these events was highest in the tolvaptan 60 mg group (54.3%) and lowest in the placebo group (33.3%). Most common adverse events (greater than 3% and more frequent than placebo) associated with tolvaptan were dry mouth, thirst, back pain, headache, anxiety, and haematuria. No treatment-emergent adverse event occurred in more than 10% of the patients in any of the groups. No deaths occurred during study drug administration. Two patients died during the 7-day follow-up period (originally assigned to tolvaptan 30 mg and 60 mg, respectively). Both of those patients died from complications resulting from worsening of underlying disease.

Ab
'/>"/>

SOURCE Otsuka America Pharmaceutical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
2. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford
3. Promising Data on Cognitive Effects of Safinamide in Early Parkinsons Disease
4. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
5. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
6. New Data Suggests Less Abuse-Related Effects For OROS Methylphenidate
7. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
8. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
9. Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacells Onconase
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Research and Markets( http://www.researchandmarkets.com/research/324sfl/global_biomedical ) has ... Metal Market 2015-2019" report to their offering. ... grow at a CAGR of 7.27% over the ... for a number of applications in the Medical ... titanium-based alloys, cobalt-based alloys, nitinol, magnesium and related ...
(Date:5/28/2015)... , May 28, 2015  Merck KGaA, ... company for innovative and top-quality high-tech products in ... a global collaboration agreement with the fertility technologies ... advancing fertility science and helping couples create families. ... Germany , a global market leader in ...
(Date:5/28/2015)... Oregon , May 28, 2015 ... "Global Syphilis Testing Market - Size, Industry Analysis, Trends, Opportunities, Growth ... to reach $3.6 billion by 2020. The secondary syphilis ... through 2020. Latin America , ... (LAMEA) market accounted for about 43% revenue ...
Breaking Medicine Technology:Global Biomedical Metal Market 2015-2019 with Biomet, Dentsply, Invibio & Wright Medical Group Dominating 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 4Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3
... Reportlinker.com announces that a new market research ... Global Medical Ultrasound Equipment ... This report analyzes the ... US$ Million by the following End-Use Segments: ...
... (Nasdaq: MYL ) today announced the appointment ... Mylan,s fully integrated specialty pharmaceutical business. ... in strategic product launches, marketing, commercialization, sales penetration and ... chief executive officer of MiddleBrook Pharmaceuticals. In this capacity, ...
Cached Medicine Technology:Global Medical Ultrasound Equipment Industry 2Global Medical Ultrasound Equipment Industry 3Global Medical Ultrasound Equipment Industry 4Global Medical Ultrasound Equipment Industry 5Global Medical Ultrasound Equipment Industry 6Global Medical Ultrasound Equipment Industry 7Global Medical Ultrasound Equipment Industry 8Global Medical Ultrasound Equipment Industry 9Global Medical Ultrasound Equipment Industry 10Global Medical Ultrasound Equipment Industry 11Global Medical Ultrasound Equipment Industry 12Global Medical Ultrasound Equipment Industry 13Global Medical Ultrasound Equipment Industry 14Global Medical Ultrasound Equipment Industry 15Global Medical Ultrasound Equipment Industry 16Global Medical Ultrasound Equipment Industry 17Global Medical Ultrasound Equipment Industry 18Global Medical Ultrasound Equipment Industry 19Global Medical Ultrasound Equipment Industry 20Global Medical Ultrasound Equipment Industry 21Global Medical Ultrasound Equipment Industry 22Global Medical Ultrasound Equipment Industry 23Global Medical Ultrasound Equipment Industry 24Global Medical Ultrasound Equipment Industry 25Mylan Names John Thievon President of Dey Pharma 2
(Date:5/29/2015)... Georgia (PRWEB) May 29, 2015 National ... celebration for Swedish nationals around the world. The celebration held ... Atlanta and in cooperation with SWEA (Swedish Women’s ... of the year for the Swedish-American community in Georgia. , ... this celebration of Swedish heritage and the long relationship between ...
(Date:5/29/2015)... New England Peptide, Inc. (NEP), in ... Analysis Consortium (CPTAC) and others, today announced the ... of peptide stable isotope standards for biomarker discovery. ... tryptic peptides, offers thousands of fragments spanning over ... accessible to the biomedical research community. Each ...
(Date:5/28/2015)... 2015 Medical Device Cybersecurity Quality ... **FDAnews Webinar**, June 23, 2015 — 1:00 p.m. ... Network connectivity opens up a wealth of possibilities ... minefield of potential liabilities. Devices transmit data on ... manufacturers be sure the information doesn’t fall into ...
(Date:5/28/2015)... May 28, 2015 External Counterpulsation (EECP/ECP) ... all over the United States. There are a growing ... who can experience symptoms of angina and these patients ... stents and/or bypass surgery. , “No option” patients are ... coronary artery disease that is considered unacceptable for heart ...
(Date:5/28/2015)... May 28, 2015 The USC Verdugo Hills ... center management for a decade with a current average healing ... between USC and Wound Care Advantage to provide in-patient wound ... for a drop in the rate of hospital-acquired pressure ... healing is a complex undertaking that can frighten patients and ...
Breaking Medicine News(10 mins):Health News:PartnerTech Co-Sponsors National Sweden Day Hosted by SACC-Georgia 2Health News:PartnerTech Co-Sponsors National Sweden Day Hosted by SACC-Georgia 3Health News:New England Peptide Announces New Tryptides™ Catalog 2Health News:New England Peptide Announces New Tryptides™ Catalog 3Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 2Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 3Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2
... Wash., April 7, 2008 The Chehalis,Confederated Tribes ... at The Lucky Eagle Casino May 17 and ... appropriately named "The,Return To Honor Veterans Benefit," will ... and Family Fund and the Freedoms Foundation,s,Return to ...
... 2008 DURECT,Corporation (Nasdaq: DRRX ) announced ... to return the rights to CHRONOGESIC(R) licensed from,DURECT ... a product,candidate consisting of a sufentanil containing implantable ... As a result, the,Development, Commercialization and Supply License ...
... Kan., April 7, 2008 With the final,stages ... Wheelchair is now available for purchase. Designed, developed,and ... of Valley,Center, Kansas, the Flight Ultralight features lightweight ... folding,frame wheelchair. The wheelchair weighs just 18 pounds ...
... VNUS(R),Medical Technologies, Inc. (Nasdaq: VNUS ), a ... of peripheral vascular,disease, announced today that it plans to ... 31, 2008, after the close of market on April,21., ... at 2:00 p.m. PT,/ 5:00 p.m. ET on April ...
... to therapeutic applications in humans, researchers say ... neurons derived from reprogrammed adult skin cells successfully ... reduced symptoms of a Parkinson,s disease-like condition in ... the first demonstration that reprogrammed cells can integrate ...
... testimonial by client and ... interview with team physician, WASHINGTON, April 7, 2008 ... nation executive,weight loss consulting service for attorneys by an attorney, announced,today ... its service.,The video will feature a testimonial by a client who ...
Cached Medicine News:Health News:Chehalis Tribes Announce Benefit to Help Returning Combat Veterans 2Health News:DURECT Provides Update on CHRONOGESIC(R) Research Program 2Health News:World's Lightest, Rigid, Folding Frame Wheelchair now in Production 2Health News:VNUS Medical Technologies to Report First-Quarter 2008 Results and Webcast Teleconference on April 21 2Health News:Reprogrammed Cells Reduce Parkinson's Symptoms 2Health News:Attorney Weight Loss Video to be Released by Leventhal Weight Loss Incorporated 2
... The original Vibratome Semi-Automatic Tissue Sectioning System ... solid tissue sectioning system. Researchers from around ... 1000 Classic for their fresh and fresh ... years. With the Vibratome Automatic ...
... provides a versatile means of sectioning fresh ... The 1500 employs a vibrating blade principle ... The creation of artifacts, the alteration ... and other deleterious effect inherent in freezing ...
The V-Block adapter is designed to allow round posts to be placed in the Vibratome vice....
... this sapphire microtomy knife makes it possible ... Vibratome sections with microscopic resolution similar to ... sections. The sapphire knife allows serial ... thickness in the 6-10 micron range with ...
Medicine Products: